Table 1.
Baseline characteristics of 500 individuals who constructed 100 pooled samples in the KCPS-II.
| Characteristic | Normal Range | Overall | Control (n = 55) |
Type 2 Diabetes (n = 30) |
Thyroid Cancer (n = 15) |
p-Value |
|---|---|---|---|---|---|---|
| Sex | n (%) | 0.795 | ||||
| Male | 48 (48.00) | 27 (49.09) | 15 (50.00) | 6 (40.00) | ||
| Female | 52 (52.00) | 28 (50.91) | 15 (50.00) | 9 (60.00) | ||
| Median (IQR) | ||||||
| Age, years | 54.06 (21.04) | 54.25 (20.57) | 54.04 (22.14) | 52.60 (19.20) | 0.813 | |
| BMI, kg/m2 | 25–29.9 | 24.28 (2.15) | 24.31 (1.94) | 24.36 (2.21) | 24.20 (1.83) | 0.619 |
| FBS, mg/dL | 70–100 | 92.88 (14.23) | 89.42 (6.73) | 135.73 (40.13) | 92.88 (7.59) | ≤0.001 |
| HDL-C, mg/dL | 40 or higher | 52.89 (9.57) | 55.20 (12.23) | 51.56 (6.70) | 50.00 (5.23) | 0.004 |
| LDL-C, mg/dL | Less than 110 | 117.32 (26.32) | 112.35 (27.29) | 121.61 (22.17) | 115.51 (18.99) | 0.046 |
| SBP, mmHg | Less than 120 | 123.71 (14.35) | 121.81 (10.95) | 129.50 (12.44) | 116.25 (16.32) | 0.005 |
| TG, mg/dL | Less than 150 | 135.95 (66.38) | 131.56 (61.10) | 163.28 (67.74) | 125.05 (45.32) | 0.009 |
| TSH, uIU/mL | 0.35–5.5 | 1.66 (0.83) | 1.66 (0.82) | 1.64 (0.79) | 1.69 (0.92) | 0.659 |
IQR, interquartile range; BMI, body mass index; SBP, systolic blood pressure; FBS, fasting blood sugar; HDL-C, high-density lipoprotein-cholesterol; LDL-C, low-density lipoprotein-cholesterol; TG, triglyceride; TSH, thyroid stimulation hormone; kg/m2, kilogram per square meter; mg/dL, milligrams per deciliter; mmHg, millimeters of mercury; uIU/mL, micro-international units per milliliter; p values from Kruskal–Wallis test and all variables are calculated by weighted blood volume.